Nan You

2.0k total citations
61 papers, 1.3k citations indexed

About

Nan You is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Nan You has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 24 papers in Hepatology and 21 papers in Oncology. Recurrent topics in Nan You's work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Liver physiology and pathology (8 papers). Nan You is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Liver physiology and pathology (8 papers). Nan You collaborates with scholars based in China, United States and Australia. Nan You's co-authors include Kaishan Tao, Kefeng Dou, Lu Zheng, Weihui Liu, Desheng Wang, Xiaobing Huang, Ru Ji, Liang Zhou, Xiaolei Li and Weiwei Wang and has published in prestigious journals such as Gastroenterology, PLoS ONE and Biomaterials.

In The Last Decade

Nan You

59 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Nan You 656 410 250 212 211 61 1.3k
Mingxin Pan 559 0.9× 415 1.0× 348 1.4× 189 0.9× 240 1.1× 72 1.2k
Jianwen Cheng 674 1.0× 279 0.7× 409 1.6× 152 0.7× 159 0.8× 53 1.2k
Tao Wei 442 0.7× 418 1.0× 361 1.4× 150 0.7× 147 0.7× 40 1.1k
Ge‐Liang Xu 661 1.0× 354 0.9× 359 1.4× 215 1.0× 121 0.6× 62 1.3k
Zhuo Lin 731 1.1× 509 1.2× 120 0.5× 380 1.8× 191 0.9× 58 1.4k
Chikashi Nakanishi 442 0.7× 314 0.8× 220 0.9× 152 0.7× 205 1.0× 49 988
Guoshan Ding 903 1.4× 777 1.9× 181 0.7× 229 1.1× 180 0.9× 54 1.6k
Guangyi Wang 478 0.7× 230 0.6× 234 0.9× 78 0.4× 146 0.7× 66 997
Weihua Ren 661 1.0× 409 1.0× 258 1.0× 93 0.4× 112 0.5× 43 1.1k

Countries citing papers authored by Nan You

Since Specialization
Citations

This map shows the geographic impact of Nan You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan You more than expected).

Fields of papers citing papers by Nan You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan You. The network helps show where Nan You may publish in the future.

Co-authorship network of co-authors of Nan You

This figure shows the co-authorship network connecting the top 25 collaborators of Nan You. A scholar is included among the top collaborators of Nan You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan You. Nan You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liang, Heng, Chuwei Liu, Arabella Wan, et al.. (2025). Machine learning-assisted tacrolimus dose optimization in childhood- onset systemic lupus erythematosus through population pharmacokinetic modeling. Computers in Biology and Medicine. 196(Pt B). 110782–110782. 1 indexed citations
3.
Wang, Ziqi, et al.. (2025). Nanoconfinement-enchanced electrochemiluminescence based on a Ru(bpy)32+-loaded mesoporous silica nanoparticles for ribavirin detection. Journal of Electroanalytical Chemistry. 994. 119274–119274. 1 indexed citations
4.
Zhao, Yan, Wei Bai, Nan You, et al.. (2025). Sorafenib combined with transarterial chemoembolization compared with sorafenib alone in advanced hepatocellular carcinoma (SELECT): a multicenter, phase 3, randomized, controlled trial. The Lancet Regional Health - Western Pacific. 55. 101300–101300. 1 indexed citations
5.
6.
7.
8.
Tang, Yichen, Yuming Li, Xuehui Peng, et al.. (2023). Clinical and genetic characteristics in pancreatic cancer from Chinese patients revealed by whole exome sequencing. Frontiers in Oncology. 13. 6 indexed citations
9.
Sun, Lei, Zhengyu Liu, Arabella Wan, et al.. (2023). Galectin-7 Induction by EHMT2 Inhibition Enhances Immunity in Microsatellite Stability Colorectal Cancer. Gastroenterology. 166(3). 466–482. 16 indexed citations
10.
Zhu, Yeqing, et al.. (2022). Bronchiectasis in Low-Dose CT Screening for Lung Cancer. Radiology. 304(2). 437–447. 10 indexed citations
11.
Li, J., Nan You, Ke Wu, et al.. (2020). P-129 Camrelizumab combined with sorafenib versus sorafenib alone in patients with advanced hepatocellular carcinoma: A retrospective study. Annals of Oncology. 31. S131–S132. 2 indexed citations
12.
Gu, Huiying, Wei Jiang, Nan You, et al.. (2020). Soluble Klotho Improves Hepatic Glucose and Lipid Homeostasis in Type 2 Diabetes. Molecular Therapy — Methods & Clinical Development. 18. 811–823. 43 indexed citations
13.
14.
Wang, Weiwei, et al.. (2017). Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction. World Journal of Gastroenterology. 23(38). 6983–6994. 81 indexed citations
15.
Shang, Yangyang, et al.. (2015). COMMD7 gene promotes HepG2 proliferation via extracellular regulated protein kinase/ mitogen-activated protein kinase signaling pathway. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 14(4). 316–320. 1 indexed citations
16.
Liu, Jie, Bai Ruan, Nan You, et al.. (2013). Downregulation of miR-200a Induces EMT Phenotypes and CSC-like Signatures through Targeting the β-catenin Pathway in Hepatic Oval Cells. PLoS ONE. 8(11). e79409–e79409. 63 indexed citations
17.
Wang, Tao, Nan You, Kaishan Tao, et al.. (2012). Notch is the key factor in the process of fetal liver stem/progenitor cells differentiation into hepatocytes. Development Growth & Differentiation. 54(5). 605–617. 26 indexed citations
18.
Liu, Weihui, Xing Wang, Nan You, et al.. (2012). Efficient Enrichment of Hepatic Cancer Stem-Like Cells from a Primary Rat HCC Model via a Density Gradient Centrifugation-Centered Method. PLoS ONE. 7(4). e35720–e35720. 19 indexed citations
19.
20.
Ji, Ru, Ning Zhang, Nan You, et al.. (2012). The differentiation of MSCs into functional hepatocyte-like cells in a liver biomatrix scaffold and their transplantation into liver-fibrotic mice. Biomaterials. 33(35). 8995–9008. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingxin Pan Breakdown of academic impact, for papers by Jianwen Cheng Breakdown of academic impact, for papers by Tao Wei Breakdown of academic impact, for papers by Ge‐Liang Xu Breakdown of academic impact, for papers by Zhuo Lin Breakdown of academic impact, for papers by Chikashi Nakanishi Breakdown of academic impact, for papers by Guoshan Ding Breakdown of academic impact, for papers by Guangyi Wang Breakdown of academic impact, for papers by Weihua Ren
Rankless by CCL
2026